Can heparin affect argatroban lab results?
Part of Heart & circulation clinical trials.
This study looks at whether the presence of heparin (a common blood thinner) can interfere with the lab test used to measure another blood thinner called argatroban. If you are already having your heparin level checked, this study uses the same blood sample to see if heparin affects argatroban results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are currently taking a blood thinner called either unfractionated heparin (UFH) or low molecular weight heparin (LMWH).
- Your doctor has already ordered a blood test to check the level of your heparin (called anti-Xa activity) and the sample was sent to the Hematology Laboratory at the University Hospitals of Strasbourg.
- You are not taking any other blood thinner besides UFH or LMWH.
- There is enough blood in the sample to run the study test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a faster spinning method to measure how well your blood thinner (anti-Xa) is working when your blood sample is fatty. It may help ensure accurate results for patients on certain anticoagulants.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This study looks back at patient records to see how antithrombin (a medicine that helps prevent blood clots) was used in intensive care or during surgery. It does not test a new treatment, but helps doctors understand if the medicine was given appropriately.
This study looks at side effects of blood thinners (anticoagulants) in patients who visited the emergency department. It helps doctors understand how to better manage these medications.
This study looks at the best time to give a standard blood thinner (heparin) during a heart procedure called angioplasty, which opens blocked heart arteries through a wrist artery. It may help reduce bleeding or clotting risks.
This study looks at whether genetic and blood test information can help manage heparin-induced thrombocytopenia (HIT), a condition where blood platelets drop after heparin use. If you’ve been evaluated for HIT and received certain heparin medicines, your results may help researchers choose safer, more personalized care.
Hear when a new Thromboembolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.